Pharmacoevidence
U72100PB2020PTC051449ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed
Pharmacoevidence is a Private Indian company incorporated in 2020 and based in Punjab, India. Pharmacoevidence operates in IT & Software (NIC 72100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2020
6 years old
State
Punjab
Sector
IT & Software
NIC 72100
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
PharmacoevidenceTRACXN · PUBLIC DATA
Brand Pharmacoevidence · Legal entity Pharmacoevidence
Pharmacoevidence - Provider of health economics and outcomes research consultancy services worldwide.
Total Funding
Latest Round
Seed
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Unfunded
HQ
Sahibzada Ajit Singh Nagar
Founded
2020
Source: Tracxn (public profile) · joined to MCA on CIN U72100PB2020PTC051449
Quick facts
Registered office
—
NIC code
72100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
IT & Software
ROC
—
Class · sub-category
Private
Incorporation · Last AGM
— · —
Directors
LockedKB
Kunal Bhatia
Whole-time Director8.2y · Chennai · DIN 2407992
PN
Priya Nair
Managing Director6.7y · Ahmedabad · DIN 6244321
Get the full board of directors
Directors, DINs & appointment history for Pharmacoevidence.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +8d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +4d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Pharmacoevidence.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 564278601 | ICICI Bank Ltd(Bank) | ₹14.54 Cr | 27 Jan 2020 | Satisfied |
| 693441355 | Kotak Mahindra Bank Ltd(Bank) | ₹5.02 Cr | 12 Mar 2021 | Open |
| 966145044 | ICICI Bank Ltd(Bank) | ₹18.60 Cr | 27 Jan 2020 | Satisfied |
| 921284197 | Axis Bank Ltd(Bank) | ₹17.45 Cr | 12 Mar 2020 | Satisfied |
| 716705214 | State Bank of India(Bank) | ₹21.53 Cr | 19 Sep 2020 | Satisfied |
See registered charges & lenders
Charge IDs, lenders & amounts for Pharmacoevidence.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹34.78 Cr | ₹4.50 Cr | ₹23.92 Cr | ₹37.69 Cr | 53 |
| FY2023-24 | ₹32.68 Cr | ₹4.35 Cr | ₹18.82 Cr | ₹34.97 Cr | 140 |
| FY2022-23 | ₹24.61 Cr | ₹3.27 Cr | ₹16.14 Cr | ₹26.24 Cr | 151 |
| FY2021-22 | ₹16.83 Cr | ₹2.23 Cr | ₹14.44 Cr | ₹25.38 Cr | 103 |
Gain deeper financial insights of this entity
Audited financials & ratios for Pharmacoevidence.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹34.78 Cr | ₹32.68 Cr | ₹24.61 Cr | ₹16.83 Cr |
| Other income | ₹1.10 Cr | ₹18.71 L | ₹97.81 L | ₹66.37 L |
| Total income | ₹35.88 Cr | ₹32.86 Cr | ₹25.59 Cr | ₹17.49 Cr |
| Total expenses | ₹30.12 Cr | ₹27.30 Cr | ₹21.41 Cr | ₹14.64 Cr |
| Profit before tax | ₹5.85 Cr | ₹5.65 Cr | ₹4.25 Cr | ₹2.90 Cr |
| Profit / (Loss) after tax | ₹4.50 Cr | ₹4.35 Cr | ₹3.27 Cr | ₹2.23 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹23.92 Cr | ₹18.82 Cr | ₹16.14 Cr | ₹14.44 Cr |
| Borrowings | ₹5.74 Cr | ₹7.93 Cr | ₹2.58 Cr | ₹5.71 Cr |
| Current liabilities | ₹7.01 Cr | ₹9.53 Cr | ₹3.72 Cr | ₹5.61 Cr |
| Total liabilities | ₹13.77 Cr | ₹16.15 Cr | ₹10.10 Cr | ₹10.95 Cr |
| Current assets | ₹22.05 Cr | ₹20.24 Cr | ₹10.56 Cr | ₹11.28 Cr |
| Cash & equivalents | ₹8.63 Cr | ₹7.61 Cr | ₹3.12 Cr | ₹3.42 Cr |
| Total assets | ₹37.69 Cr | ₹34.97 Cr | ₹26.24 Cr | ₹25.38 Cr |
| Employees | 53 | 140 | 151 | 103 |
Gain deeper financial insights of this entity
Audited financials & ratios for Pharmacoevidence.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹34.78 Cr | +17.7% | +3.8% | +11.6% |
| Profit after Tax | ₹4.50 Cr | +25.1% | -6.0% | +10.4% |
| Net Worth | ₹23.92 Cr | -4.4% | +2.7% | +18.0% |
| Employees | 53 | +3.2% | +10.4% | +2.7% |
Gain deeper financial insights of this entity
Audited financials & ratios for Pharmacoevidence.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹34.78 Cr | ₹4.50 Cr | +12.94% | +1.37% | +18.81% | +11.94% | 0.24 | ₹65.63 L |
| FY2023-24 | ₹32.68 Cr | ₹4.35 Cr | +13.30% | -9.58% | +23.10% | +12.43% | 0.42 | ₹23.34 L |
| FY2022-23 | ₹24.61 Cr | ₹3.27 Cr | +13.27% | +26.31% | +20.24% | +12.45% | 0.16 | ₹16.30 L |
| FY2021-22 | ₹16.83 Cr | ₹2.23 Cr | +13.26% | -6.77% | +15.45% | +8.79% | 0.40 | ₹16.34 L |
Gain deeper financial insights of this entity
Audited financials & ratios for Pharmacoevidence.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 1,86,17,690 | 73.10% |
| Institutional Investors | 2 | 34,00,410 | 13.35% |
| Public & Others | 9 | 34,52,230 | 13.55% |
See the full shareholding pattern
Promoter, institutional & public holding for Pharmacoevidence.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
17 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
63
63
Bottom quartile · P0
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Pharmacoevidence
When was Pharmacoevidence incorporated?
Pharmacoevidence was incorporated in 2020. Its CIN is U72100PB2020PTC051449 and it is registered with the relevant Registrar of Companies.
Where is Pharmacoevidence located?
Pharmacoevidence is headquartered in Punjab.
What sector does Pharmacoevidence operate in?
Pharmacoevidence operates in the IT & Software sector (NIC code 72100), classified as Indian Non-Govt Company.
Who are the directors of Pharmacoevidence?
Director details for Pharmacoevidence have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Pharmacoevidence?
Pharmacoevidence has authorized capital of — and paid-up capital of —.
Does Pharmacoevidence have any open charges?
Pharmacoevidence has no open MCA-registered charges on record.
What is Pharmacoevidence's Compliance Health Score?
RegisterKaro's Compliance Health Score for Pharmacoevidence is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.